|
Quotes & Info
|
| ARRY > SEC Filings for ARRY > Form 8-K on 20-Apr-2009 | All Recent SEC Filings |
20-Apr-2009
Other Events, Financial Statements and Exhibits
On April 19, 2009, Array BioPharma Inc. issued a press release announcing that ARRY-614 demonstrates cytokine inhibition and anti-tumor activity in preclinical models of hematological cancers. The full text of this press release is attached hereto as Exhibit 99.1.
(d) Exhibits.
99.1 Press release dated April 19, 2009 entitled "Array BioPharma's ARRY-614 Demonstrates Cytokine Inhibition and Anti-tumor Activity in Preclinical Models of Hematological Cancers."
|
|